Sign in

CIK 0001858848 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Tenaya Therapeutics, Inc.

Sign in to watch
Ticker
TNYA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
813789973
Phone
415-865-2066
Business address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA, 94080
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. DEFA14A Proxy Proxy Materials
  4. DEF 14A Proxy Proxy Statement
  5. PRE 14A Proxy Proxy Statement (Preliminary)
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 144 Insider Sale of Securities
  12. 144 Insider Sale of Securities
  13. S-8 Other Securities Offered to Employees in Benefit Plans
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. 3 Insider Initial Statement of Ownership
  17. 4 Insider Changes in Ownership
  18. 8-K Event Agreement ended
  19. 8-K Event Executive or director change · Regulation FD disclosure
  20. 4 Insider Changes in Ownership

Page 1 of 18 · 353 filings